The GALNT3 gene helps the body control phosphate, a mineral that supports bones and teeth. This gene plays an important role in preparing certain proteins so a hormone called FGF23 can keep phosphate levels in balance. If the GALNT3 gene does not work properly, phosphate can rise too high and calcium phosphate may collect in soft tissues, causing hard lumps near joints, bone pain, or repeated inflammation. GALNT3 is mainly known in medicine for its link to rare inherited conditions such as familial tumoral calcinosis.
What is a gene?
Genes are segments of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do the work. Others mainly help control when and where certain processes take place and how strongly they operate. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
GALNT3Gene function
What if the gene works
The GALNT3 gene helps your body control phosphate, a mineral important for bones and teeth. It does this by adding a small sugar tag to FGF23 (a hormone that helps the kidneys manage phosphate).
Risk
What if the gene does not work
Pathogenic variants in the GALNT3 gene can cause high phosphate levels, with calcium deposits around joints and sometimes painful bone swelling. Effects can range from milder to more severe, with different ages of onset and different features.
Treatment
What does that mean for your treatment
No GALNT3-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the GALNT3 gene. GALNT3 is being studied within the FGF23 phosphate pathway as a possible future treatment target, but this has not yet changed routine care.
Conditions associated with GALNT3
Gene function
What if the gene works
Your cells use the GALNT3 gene during the final preparation of certain proteins before those proteins are released or put to work. It adds small sugar tags that help some proteins keep the right shape and timing. A key part of this job is helping the body regulate phosphate in a steady way.
The GALNT3 gene helps add small sugar tags to selected proteins inside the cell. This finishing step supports normal protein handling as those proteins move through the cell’s packaging system.
One important target of GALNT3 is FGF23, a hormone signal that helps control phosphate levels. The sugar tag added by GALNT3 helps FGF23 stay intact long enough to do its job.
By supporting normal FGF23 handling, the GALNT3 gene helps the body handle phosphate in a coordinated way. This supports steady phosphate levels that matter for bones, teeth, and routine cell activity.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
A variant in the GALNT3 gene that affects protein function can change the enzyme’s shape, stability, or ability to add a small sugar tag to FGF23, a hormone that helps control phosphate. When that tag is missing, FGF23 is more easily cut into inactive pieces. More severe variants may nearly abolish enzyme activity or stop the protein from being made, while milder variants can leave some activity and may be linked to later onset or less marked calcium deposits.
How variants are linked to conditions
Pathogenic variants in both copies of the GALNT3 gene cause hyperphosphatemic familial tumoral calcinosis, the main condition linked to GALNT3 gene variants. People with this condition can develop hard calcium deposits near large joints, along with bone pain, swelling, or limited movement. Some may also have a closely related presentation with repeated painful bone inflammation and thickening, sometimes described as hyperostosis hyperphosphatemia syndrome.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. In certain situations, though, one well-characterized variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For GALNT3-related conditions, risk is driven mainly by inheriting harmful changes in both copies of the GALNT3 gene. High phosphate levels in the body, including from phosphate-rich foods or some supplements, can make calcium deposits and related problems worse. Regular follow-up helps spot complications early.
Inheritance of GALNT3 variants
Variants in the GALNT3 gene are inherited in an autosomal recessive pattern. This means a person usually develops a GALNT3 related condition only when they inherit one altered copy from each parent, while parents with one altered copy are typically carriers without the condition. In families asking about the GALNT3 inheritance pattern, each pregnancy between two carriers has a 25% chance of a child with the condition, a 50% chance of a carrier child, and a 25% chance of a child without either altered copy.
What does my GALNT3 result mean for my family?
For families with a disease-causing GALNT3 result, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, so the result can matter for close relatives. Children of someone with GALNT3-related disease will usually be carriers, and the chance of having an affected child depends on whether the other parent also carries a changed GALNT3 copy.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the GALNT3 gene, genetic testing for GALNT3 variants uses a blood or saliva sample. A lab reads the DNA sequence and compares it with the usual gene code to look for variants, then reports whether a finding helps confirm a genetic diagnosis or shows carrier status.
When should I consider getting a genetic test?
Consider GALNT3 genetic testing if someone has unexplained high phosphate, a blood mineral, painful calcium-like lumps around the joints, or repeated episodes of bone swelling, especially when these problems run in the family. A result can help confirm an inherited cause and guide testing for relatives.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the specific type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can have different effects in different people. With many drugs, genes influence both how the body handles the medicine and how strong its effects are. This information can support more informed, personalized treatment decisions. More detail is available in the LearnHub.
Drugs influenced by the GALNT3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about symptoms, treatment, or possible medicine side effects are best discussed with your doctor.
History
GALNT3 entered medical genetics in the early 2000s, when researchers studying families with unusual calcium phosphate deposits identified harmful variants in the GALNT3 gene. Inheritance patterns were noticed long before the gene was identified. This discovery helped connect familial tumoral calcinosis and hyperostosis hyperphosphatemia syndrome, showing they were closely related conditions rather than entirely separate illnesses. From these first observations, research expanded steadily. Over time, reports from different countries confirmed the gene’s role and gave doctors a clearer way to classify these inherited phosphate balance conditions.